Showing results 3 to 5 of 5
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors Journal:Invest New Drugs | 2014 | ||
2014 | |||
A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors Journal:Cancer Chemotherapy and Pharmacology | 2015 |